In patients with MS, the immunomodulatory effects of vitamin D were found to be greater in females than in males including inhibition of T cell proliferation, reduction in IFN-γ and IL-17, and an increase in Tregs and IL-10-secreting cells (295). This evidence concerns the gene IFNG and myeloid sarcoma.